Updates

October 16, 2019
Kisqali-Faslodex Combo Prolongs Survival of Postmenopausal Women with Advanced Breast Cancer, Phase 3 Trial Shows

Kisqali (ribociclib) in combination with Faslodex (fulvestrant) prolongs the survival of postmenopausal women with HR-positive, HER2-negative, advanced or metastatic breast cancer, interim analysis of ... Read more
October 14, 2019October 14, 2019
Hormone Therapy-Chemo Combo Reduces Risk of Tumor Return in Highly Recurrent Breast Cancer, Phase 3 Trial Shows

Using chemotherapy in combination with hormone therapy in women with highly recurring forms of breast cancer reduces the likelihood of disease returning elsewhere in the body ... Read more
October 9, 2019
Terranea Resort Turns Pink for National Breast Cancer Awareness Month

In observance of National Breast Cancer Awareness Month, the Los Angeles oceanfront resort Terranea will again “turn pink” to benefit breast cancer organizations. Throughout ... Read more
October 7, 2019
Veliparib-Chemo Combo Prolongs Survival Without Disease Progression in Certain Advanced Breast Cancer Patients, Phase 3 Trial Shows

Veliparib in combination with chemotherapy significantly prolongs survival without disease progression in women with metastatic HER2-negative breast cancer with BRCA mutations, compared with ... Read more
October 4, 2019October 7, 2019
Verzenio-Faslodex Combo Prolongs Survival of Women with Advanced Breast Cancer, Phase 3 Trial Shows

Verzenio (abemaciclib) in combination with Faslodex (fulvestrant) prolongs the survival of women with HR-positive, HER2-negative, advanced or metastatic breast cancer who had been treated ... Read more

News

PINKTOBER Events at Hard Rock Promote Breast Cancer Awareness
October 2, 2019
Marking 20 years of support for breast cancer awareness and research, Hard Rock International has kicked ...
News

First Patients Dosed in Phase 1 Trial Testing ARV-471 in Advanced, ER-Positive Breast Cancer
September 30, 2019
The first patients have been dosed in a Phase 1 trial evaluating Arvinas‘ experimental ...
News

Mylan Launches Generic Version of Faslodex Injection in the US
September 27, 2019October 16, 2019
The U.S. Food and Drug Administration has approved Mylan‘s generic version of AstraZeneca‘s Faslodex ...
News

For Breast Cancer Awareness Month, Life Image Offering Free Access to Mammosphere App
September 25, 2019October 7, 2019
Because access to prior mammograms is critical for women during all stages of breast ...
News

New Herceptin-Perjeta Formulation Shows Promising Safety and Pharmacokinetic Profile, Phase 3 Trial Shows
September 23, 2019
When given together with Herceptin (trastuzumab) at a fixed dose through an under-the-skin (subcutaneous) ...
News

FDA OKs Use of Tool to Predict Patient Response to New Form of Cisplatin in Planned Phase 3 Study
September 20, 2019September 20, 2019
The U.S. Food and Drug Administration (FDA) has approved use of a device, called ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Herceptin Developers Granted 2019 Lasker-DeBakey Research Award
September 18, 2019
The 2019 Lasker-DeBakey Clinical Medical Research Award has been granted to scientists H. Michael Shepard, ...
TNBC Patient Given Investigative Antibody, Leronlimab, Under Emergency Exception
September 16, 2019
A metastatic triple-negative breast cancer (TNBC) patient is being treated with CytoDyn’s investigational leronlimab ...
FDA to Review Nerlynx Combo as Third-line Treatment for HER2-positive Metastatic Breast Cancer
September 13, 2019September 13, 2019
Music Helps Ease Pain and Fatigue of Breast Cancer, Study Shows
September 11, 2019
Cancer by the Numbers
September 10, 2019September 5, 2019
Nerlynx Granted FDA’s Orphan Drug Status for Treating Breast Cancer with Brain Metastases
September 9, 2019September 9, 2019

Longer Use of Hormone Replacement Therapy Linked to Greater Breast Cancer Risk in Study
September 6, 2019
The longer women use hormone therapy after menopause the higher is their breast cancer ...
FDA Urges Inclusion of Men in Clinical Trials for Breast Cancer Treatment
September 4, 2019
Tecentriq-Abraxane Combo OK’d in EU to Treat Certain Advanced Triple-negative Breast Cancers
August 30, 2019
USPSTF Updates Recommendations on Testing for BRCA-related Cancers in Women
August 28, 2019

10 Commandments for Surviving Breast Cancer
August 27, 2019August 22, 2019
I hate giving advice, but I’ve learned lessons through my breast cancer journey that ...
Grant to Fund CAR T-cell Trial for HER2-Positive BC with Brain Metastases
August 26, 2019September 18, 2019
Oral Paclitaxel Combo Leads to Better Response Rates Than IV Therapy in MBC, Data Shows
August 23, 2019August 23, 2019

News

FDA Approves Rozlytrek for Breast Cancer, Other Solid Tumors with Specific Gene Defect
August 21, 2019
The U.S. Food and Drug Administration (FDA) has approved Rozlytrek (entrectinib) as an oral ...
News

Phase 2 Trial of NeuVax Vaccine for HER2-positive DCIS Fully Enrolled, Sellas Announces
August 19, 2019
The Phase 2 trial evaluating Sellas Life Sciences‘ cancer vaccine NeuVax as a treatment for ...
News

Trial Testing Eftilagimod Alpha-Chemo Combo for HR-positive Advanced Breast Cancers Now Fully Enrolled
August 16, 2019
Immunotep has completed patient enrollment for its Phase 2b trial evaluating eftilagimod alpha (IMP321) ...
News

Eagle Prepares Clinical Trials of New Form of Fulvestrant to Treat ER-positive Breast Cancer
August 14, 2019
Eagle Pharmaceuticals is preparing a pilot study that may pave the way for a ...
A Lump in the Road - A Column by Nancy Brier, Columns

‘Chemopause’: Too Hot to Trot
August 13, 2019August 9, 2019
My boss brought it up a couple of times, but the rule was clear: ...
News

Fujifilm’s New Imaging Option Can Enhance Accuracy of Breast Biopsy
August 12, 2019August 26, 2019
Fujifilm Medical Systems USA has expanded its breast cancer imaging toolbox by releasing a ...
News

Test Being Developed to Determine Risk of Recurrence in Triple-negative Breast Cancer
August 9, 2019
A new test — based on genetic markers of immune response and with potential ...
News

Keytruda Plus Chemo Increases Percentage of TNBC Patients With No Cancer Signs, Interim Analysis Shows
August 7, 2019September 10, 2019
Using Keytruda (pembrolizumab) in combination with chemotherapy increased the percentage of patients showing no ...
News

First Generic Version of Navelbine Launched in Europe for Breast, Lung Cancers
August 5, 2019September 10, 2019
Lotus Pharmaceuticals has launched the first generic version of Pierre Fabre’s Navelbine (vinorelbine) in ...
News

Verzenio-Faslodex Combo Prolongs Survival in Advanced Breast Cancer, Interim Phase 3 Data Show
August 2, 2019
Verzenio (abemaciclib) in combination with Faslodex (fulvestrant) prolongs the survival of women with HR-positive, ...
News

Team Will Use $10K Award to Bring Anti-lymphedema Bra to Market
July 31, 2019August 26, 2019
A team of recent University of Iowa (UI) graduates who designed a bra to ...
News

Anixa Partners with Cleveland Clinic to Take Breast Cancer Vaccine to Human Trials
July 29, 2019July 29, 2019
Anixa Biosciences, a leading company developing anti-cancer immunotherapies, is partnering with the Cleveland Clinic ...
News

FDA Approves Clinical Testing of Minerva’s CAR T-cell Therapy for Metastatic BC
July 26, 2019
Minerva Biotechnologies will soon start the first human trials testing its investigational therapy huMNC2-CAR44, ...
News

Combining Breast, Lung Cancer Therapies Could Overcome Treatment Resistance
July 24, 2019
Combining Ibrance (palbociclib), a treatment for advanced breast cancer, with the lung cancer medicine crizotinib is ...
A Lump in the Road - A Column by Nancy Brier, Columns

Breast Cancer? Put It on Ice
July 23, 2019July 17, 2019
The bad news? It was cancer. The good news? It was in the early ...
News

Antibody-Drug Conjugate Shows Efficacy in Heavily Treated Cancers
July 22, 2019
An investigational antibody-drug conjugate made of the HER2-targeting antibody trastuzumab (marketed as Herceptin and ...
News

Genomic Analysis Reveals Differences Between Cancer Cell Lines and Human Cancers
July 19, 2019
New research using “big data” helps highlight the differences between breast cancer cell lines ...
News

Trilaciclib-Chemo Combo Extends Lives of Triple-negative Breast Cancer Patients, Preliminary Phase 2 Findings Show
July 17, 2019
Trilaciclib, a treatment that protects the bone marrow from the damaging effects of chemotherapy, ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Pin It on Pinterest